Found: 52
Select item for more details and to access through your institution.
Situational prevention: Pharmacotherapy during periods of increased risk for migraine attacks.
- Published in:
- Headache: The Journal of Head & Face Pain, 2024, v. 64, n. 7, p. 859, doi. 10.1111/head.14775
- By:
- Publication type:
- Article
Multimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review.
- Published in:
- Neurology & Therapy, 2023, v. 12, n. 5, p. 1533, doi. 10.1007/s40120-023-00529-x
- By:
- Publication type:
- Article
Injection technique of the upper face with onabotulinumtoxinA in chronic migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 7, p. 849, doi. 10.1111/head.14588
- By:
- Publication type:
- Article
Phase Ib, open‐label, fixed‐sequence, drug–drug interaction, safety, and tolerability study between atogepant and ubrogepant in participants with a history of migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 3, p. 322, doi. 10.1111/head.14433
- By:
- Publication type:
- Article
Remote electrical neuromodulation for migraine prevention: A double‐blind, randomized, placebo‐controlled clinical trial.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 3, p. 377, doi. 10.1111/head.14469
- By:
- Publication type:
- Article
Post hoc analysis of clinical trial data and pharmacokinetic data to assess wearing‐off of erenumab within monthly treatment cycle.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 2, p. 233, doi. 10.1111/head.14403
- By:
- Publication type:
- Article
Effectiveness and Safety of Chronic Migraine Preventive Treatments: A Systematic Literature Review.
- Published in:
- Pain & Therapy, 2023, v. 12, n. 1, p. 251, doi. 10.1007/s40122-022-00452-3
- By:
- Publication type:
- Article
Once‐daily oral atogepant for the long‐term preventive treatment of migraine: Findings from a multicenter, randomized, open‐label, phase 3 trial.
- Published in:
- Headache: The Journal of Head & Face Pain, 2023, v. 63, n. 1, p. 79, doi. 10.1111/head.14439
- By:
- Publication type:
- Article
Rates of Response to Atogepant for Migraine Prophylaxis Among Adults: A Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 6, p. e2215499, doi. 10.1001/jamanetworkopen.2022.15499
- By:
- Publication type:
- Article
Erenumab dosage for migraine prevention: An evidence‐based narrative review with recommendations.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 4, p. 420, doi. 10.1111/head.14266
- By:
- Publication type:
- Article
Adjunctive treatment of chronic migraine using an oral dental device: overview and results of a randomized placebo-controlled crossover study.
- Published in:
- BMC Neurology, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12883-022-02591-8
- By:
- Publication type:
- Article
Does "wearing off" of efficacy occur in galcanezumab‐treated patients at the end of the monthly treatment cycle? Post hoc analyses of four phase III randomized trials.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 2, p. 198, doi. 10.1111/head.14257
- By:
- Publication type:
- Article
Ubrogepant Is Safe and Efficacious in Participants Taking Concomitant Preventive Medication for Migraine: A Pooled Analysis of Phase 3 Trials.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 1, p. 692, doi. 10.1007/s12325-021-01923-3
- By:
- Publication type:
- Article
Combination CGRP monoclonal antibody and onabotulinumtoxinA treatment for preventive treatment in chronic migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 1, p. 106, doi. 10.1111/head.14244
- By:
- Publication type:
- Article
Real-World Evidence for Control of Chronic Migraine Patients Receiving CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA: A Retrospective Chart Review.
- Published in:
- Pain & Therapy, 2021, v. 10, n. 2, p. 809, doi. 10.1007/s40122-021-00264-x
- By:
- Publication type:
- Article
Safety and efficacy of ubrogepant in participants with major cardiovascular risk factors in two single-attack phase 3 randomized trials: ACHIEVE I and II.
- Published in:
- Cephalalgia, 2021, v. 41, n. 9, p. 979, doi. 10.1177/03331024211000311
- By:
- Publication type:
- Article
Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implications.
- Published in:
- Cephalalgia, 2021, v. 41, n. 5, p. 546, doi. 10.1177/0333102420970523
- By:
- Publication type:
- Article
Pharmacokinetics and safety of ubrogepant when coadministered with calcitonin gene‒related peptide‐targeted monoclonal antibody migraine preventives in participants with migraine: A randomized phase 1b drug–drug interaction study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 4, p. 642, doi. 10.1111/head.14095
- By:
- Publication type:
- Article
Efficacy of ubrogepant based on prior exposure and response to triptans: A post hoc analysis.
- Published in:
- Headache: The Journal of Head & Face Pain, 2021, v. 61, n. 3, p. 422, doi. 10.1111/head.14089
- By:
- Publication type:
- Article
No "Wearing‐Off Effect" Seen in Quarterly or Monthly Dosing of Fremanezumab: Subanalysis of a Randomized Long‐Term Study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 10, p. 2431, doi. 10.1111/head.13994
- By:
- Publication type:
- Article
Response to "Modifications to the PREEMPT Protocol for OnabotulinumtoxinA Injections for Chronic Migraine in Clinical Practice".
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Clinician-Patient Dialogue About Preventive Chronic Migraine Treatment.
- Published in:
- Journal of Primary Care & Community Health, 2020, p. 1, doi. 10.1177/2150132720959935
- By:
- Publication type:
- Article
Patient-Reported Outcomes from a 1-Year, Real-World, Head-to-Head Comparison of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine.
- Published in:
- Journal of Primary Care & Community Health, 2020, p. 1, doi. 10.1177/2150132720959936
- By:
- Publication type:
- Article
Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review.
- Published in:
- Headache: The Journal of Head & Face Pain, 2020, v. 60, n. 7, p. 1259, doi. 10.1111/head.13849
- By:
- Publication type:
- Article
Lasmiditan mechanism of action – review of a selective 5-HT1F agonist.
- Published in:
- Journal of Headache & Pain, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s10194-020-01132-3
- By:
- Publication type:
- Article
Pharmacology and Pharmacokinetics of Ubrogepant: A Potent, Selective Calcitonin Gene-Related Peptide Receptor Antagonist for the Acute Treatment of Migraine.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinician-Patient Dialogue About Preventive Chronic Migraine Treatment.
- Published in:
- Journal of Primary Care & Community Health, 2020, p. 1, doi. 10.1177/2150132720959935
- By:
- Publication type:
- Article
Patient-Reported Outcomes from a 1-Year, Real-World, Head-to-Head Comparison of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine.
- Published in:
- Journal of Primary Care & Community Health, 2020, p. 1, doi. 10.1177/2150132720959936
- By:
- Publication type:
- Article
FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2019, v. 59, n. 10, p. 1700, doi. 10.1111/head.13653
- By:
- Publication type:
- Article
Long-Term Safety and Tolerability of OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: Results of the COMPEL Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Long-term safety and efficacy of onabotulinumtoxinA for the prevention of chronic migraine in a South Korean population: COMPEL study.
- Published in:
- Neurology Asia, 2019, v. 24, n. 2, p. 127
- By:
- Publication type:
- Article
Effects of onabotulinumtoxinA treatment in chronic migraine patients with and without daily headache at baseline: results from the COMPEL Study.
- Published in:
- Journal of Headache & Pain, 2019, v. 20, n. 1, p. 1, doi. 10.1186/s10194-018-0953-0
- By:
- Publication type:
- Article
Effects of onabotulinumtoxinA treatment in patients with and without allodynia: results of the COMPEL study.
- Published in:
- Journal of Headache & Pain, 2019, v. 20, n. 1, p. 1, doi. 10.1186/s10194-018-0952-1
- By:
- Publication type:
- Article
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study.
- Published in:
- Journal of Headache & Pain, 2018, v. 19, n. 1, p. 0, doi. 10.1186/s10194-018-0840-8
- By:
- Publication type:
- Article
Poster 114: Efficacy and Safety of OnabotulinumtoxinA in an Open‐Label Study for the Prophylactic Treatment of Chronic Migraine in Adult Patients: COMPEL.
- Published in:
- PM & R: Journal of Injury, Function & Rehabilitation, 2017, v. 9, n. 91, p. S171, doi. 10.1016/j.pmrj.2017.08.061
- By:
- Publication type:
- Article
Poster 114: Efficacy and Safety of OnabotulinumtoxinA in an Open-Label Study for the Prophylactic Treatment of Chronic Migraine in Adult Patients: COMPEL.
- Published in:
- PM & R: Journal of Injury, Function & Rehabilitation, 2017, v. 9, p. S171, doi. 10.1016/j.pmrj.2017.08.061
- By:
- Publication type:
- Article
Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: Guidance on Achieving Optimal Outcomes.
- Published in:
- Headache: The Journal of Head & Face Pain, 2017, v. 57, n. 5, p. 766, doi. 10.1111/head.13074
- By:
- Publication type:
- Article
Improving the detection of chronic migraine: Development and validation of Identify Chronic Migraine (ID-CM).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Direct and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web-Based Survey.
- Published in:
- Headache: The Journal of Head & Face Pain, 2016, v. 56, n. 2, p. 306, doi. 10.1111/head.12755
- By:
- Publication type:
- Article
Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine.
- Published in:
- BMC Neurology, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12883-015-0353-x
- By:
- Publication type:
- Article
Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine.
- Published in:
- BMC Neurology, 2015, v. 15, n. 1, p. 100, doi. 10.1186/s12883-015-0353-x
- By:
- Publication type:
- Article
Unmet clinical needs in chronic migraine: Rationale for study and design of COMPEL, an open-label, multicenter study of the long-term efficacy, safety, and tolerability of onabotulinumtoxinA for headache prophylaxis in adults with chronic migraine.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study ( IBMS-II).
- Published in:
- Headache: The Journal of Head & Face Pain, 2013, v. 53, n. 4, p. 644, doi. 10.1111/head.12055
- By:
- Publication type:
- Article
Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study ( IBMS-II)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
The International Burden of Migraine Study (IBMS): Study design, methodology, and baseline cohort characteristics.
- Published in:
- Cephalalgia, 2011, v. 31, n. 10, p. 1116, doi. 10.1177/0333102411410610
- By:
- Publication type:
- Article
Cost of Health Care Among Patients With Chronic and Episodic Migraine in Canada and the USA: Results From the International Burden of Migraine Study (IBMS).
- Published in:
- Headache: The Journal of Head & Face Pain, 2011, v. 51, n. 7, p. 1058, doi. 10.1111/j.1526-4610.2011.01945.x
- By:
- Publication type:
- Article
Cost of Health Care Among Patients With Chronic and Episodic Migraine in Canada and the USA: Results From the International Burden of Migraine Study (IBMS)
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
A Multi-Center Double-Blind Pilot Comparison of OnabotulinumtoxinA and Topiramate for the Prophylactic Treatment of Chronic Migraine.
- Published in:
- Headache: The Journal of Head & Face Pain, 2011, v. 51, n. 1, p. 21, doi. 10.1111/j.1526-4610.2010.01796.x
- By:
- Publication type:
- Article
Injection Procedure Record for OnabotulinumtoxinA (BOTOX.
- Published in:
- 2011
- By:
- Publication type:
- Other
Injection procedure record for onabotulinumtoxin A (Botox®, Allergan, Inc., Irvine, CA, USA) treatment.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article